by PRI | Jun 20, 2022 | Microbiome Research & Technology (public)
Sidonie LAVERGNE Scientific Director & Director of Translational Research Integrated Cancer Center...
by PRI | Jun 17, 2022 | Microbiome Product Developer
Cyrille Jeune COO (interim) everImmune leverages the potential of the gut microbiota for the development of therapeutic (Oncobax®) and diagnosis tools in cancer....
by PRI | Jun 17, 2022 | Pharma (Veterinary)
Anne Cadoux Head of Regulatory Affairs Animal Health Care Products Boehringer Ingelheim Animal Health France is born from Merial in 2018 further to the acquisition of Merial by Boehringer Ingelheim, a large pharmaceutical company with a small Animal Health department....
by PRI | Jun 17, 2022 | Microbiome Pre-Clinical Research (CRO)
Bruno Bariohay CEO BIOMEOSTASIS provides preclinical in vivo pharmacology services in the field of metabolic, GI and aged-related disorders....
by PRI | Jun 17, 2022 | Microbiome Analysis Expertise (service provider), Microbiome Clinical Research (CRO)
Benoit Fouchaq CEO Biofortis is a unique full services CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health....
